Johnson & Johnson's new pulmonary arterial hypertension drug approved for a new indication

The official website of the National Medical Products Administration shows that Johnson & Johnson's macitentan dispersible tablets have been approved for marketing, with the speculated indication being pediatric pulmonary arterial hypertension.